Highly Potent and Selective Dopamine D<sub>4</sub> Receptor Antagonists Potentially Useful for the Treatment of Glioblastoma

Pegi Pavletić, Ana Semeano, Hideaki Yano, Alessandro Bonifazi, Gianfabio Giorgioni, Alessandro Piergentili, Wilma Quaglia, Maria Giovanna Sabbieti, Dimitrios Agas, Giorgio Santoni,

Journal of Medicinal Chemistry · 2022 · 17 citations · 38 references

DOIFull text

Open access

Concepts

Abstract

induced an increased effect in reducing the cell viability with respect to temozolomide, which is the first-choice chemotherapeutic drug in GBM.

References

38